Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU

被引:44
作者
Tamura, M
Ajayi, T
Allmond, LR
Moriyama, K
Wiener-Kronish, JP
Sawa, T [1 ]
机构
[1] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
关键词
Pseudomonas aeruginosa; type III secretion system; ExoU; phospholipase A; lysophospholipase A; acute lung injury; cytotoxin;
D O I
10.1016/j.bbrc.2004.02.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lung injury in Pseudomonas aeruginosa pneumonia depends primarily on ExoU that is delivered directly into the eukaryotic cell via the type III secretion system. Recent studies demonstrated that ExoU has lipase activity, and that the cytotoxicity of ExoU is dependent on its patatin-like phospholipase domain. We investigated the phospholipase A (PLA) activity of ExoU. ExoU, but not non-catalytic ExoU-S142A, preincubated with the BEAS-2B cell lysate showed a weak increase of Ca2+-independent PLA(2) activity. When activated ExoU was mixed with secretory type PLA2, more phospholipase activity was observed, suggesting that ExoU has lysophospholipase A (lysoPLA) activity. A significant increase in lysoPLA activity was also observed. Glycerol enhanced this activity and inhibitors of iPLA, suppressed ExoUs lysoPLA activity. Our results suggest that ExoU has a potent lysoPLA activity that requires the presence of the catalytically active site Ser(142) with an unknown eukaryotic cell factor(s) for its activation. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 38 条
  • [1] CHARACTERIZATION OF THE LIPID ACYL HYDROLASE ACTIVITY OF THE MAJOR POTATO (SOLANUM-TUBEROSUM) TUBER PROTEIN, PATATIN, BY CLONING AND ABUNDANT EXPRESSION IN A BACULOVIRUS VECTOR
    ANDREWS, DL
    BEAMES, B
    SUMMERS, MD
    PARK, WD
    [J]. BIOCHEMICAL JOURNAL, 1988, 252 (01) : 199 - 206
  • [2] Barbieri JT, 2000, INT J MED MICROBIOL, V290, P381
  • [3] Ventilator-associated pneumonia
    Chastre, J
    Fagon, JY
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 867 - 903
  • [4] COBURN J, 1991, J BIOL CHEM, V266, P6438
  • [5] CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019
  • [6] Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: Assessment by quantitative culture of samples obtained by a protected specimen brush
    Fagon, JY
    Chastre, J
    Domart, Y
    Trouillet, JL
    Gibert, C
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 538 - 542
  • [7] Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
    Feltman, H
    Schulert, G
    Khan, S
    Jain, M
    Peterson, L
    Hauser, AR
    [J]. MICROBIOLOGY-SGM, 2001, 147 : 2659 - 2669
  • [8] Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU
    Finck-Barbançon, V
    Frank, DW
    [J]. JOURNAL OF BACTERIOLOGY, 2001, 183 (14) : 4330 - 4344
  • [9] ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
    FinckBarbancon, V
    Goranson, J
    Zhu, L
    Sawa, T
    WienerKronish, JP
    Fleiszig, SMJ
    Wu, C
    MendeMueller, L
    Frank, DW
    [J]. MOLECULAR MICROBIOLOGY, 1997, 25 (03) : 547 - 557
  • [10] The exoenzyme S regulon of Pseudomonas aeruginosa
    Frank, DW
    [J]. MOLECULAR MICROBIOLOGY, 1997, 26 (04) : 621 - 629